A patient presenting with newly diagnosed renal failure usually undergoes radiological evaluation to assess the number of kidneys, their size, shape and position, and whether they are obstructed and perfused. An underlying cause such as calculi, retroperitoneal fibrosis or polycystic disease should also be sought. The development of new imaging techniques, particularly real time ultrasound together with advances in interventional uroradiology in the past 10 years have revolutionised the management of the renal failure patient. These advances have led to the rapid identification and treatment of the most important group, those with surgically remediable causes. Prior to the mid sixties, retrograde pyelography reigned supreme as the primary investigation. Whilst it had the potential disadvantage of invasiveness leading to sepsis, and the need for general anaesthesia and urological expertise, it did have the advantage of rapid and reliable diagnosis of obstructive uropathy. It also gave an indication of renal size, and thus the chronicity of the process, and demonstrated pelvicalyceal abnormalities, e.g., papillary necrosis, and the distorted architecture of polycystic disease. The use of this technique in renal failure was stongly advocated by Kingston and colleagues as recently as 1977, suprisingly, the last article on renal failure in Clinical Radiology. Prior to the landmark paper by Schwartz and colleagues (1963) highlighting the 'benignity' of intravenous urography in renal insufficiency, the procedure had always been considered both dangerous and unrewarding in this group of patients. Subsequent authors (Mahaffy et al., 1969, Brown et al., 1970) confirmed that even in advanced renal failure both calyceal systems and renal outlines could be visualised in over 90% of all patients, and high dose urography rapidly became the cornerstone of renal failure radiology. Good renal failure urography however demands a high dose of contrast medium (600 mg Iodine/kg), no dehydration, linear tomography pre- and post-injection of contrast medium, delayed films up to 24 h, low and constant kilovoltage setting for maximum contrast, and above all a meticulous radiographic technique. Obtaining the latter was not helped in our hospital by most new renal failure patients arriving on Friday, and thus urograms were sometimes performed over the weekend by changing shifts of radiographers. Never were so many films taken by so many different people for such a long time for the benefit of so few with so little supervision. Initial enthusiasm was somewhat dampened by reports, mostly from the United States of America, that contrast medium might precipitate further renal impairment. Although mainly a problem in America, Webb et al. (1981) showed transient deterioration of function in three out of 40 patients (7.5%) with renal failure after intravenous urography. Rahimi et al. (1981) however, showed no deterioration of function in a group of 15 patients who had varying degrees of renal failure and were monitored for 3 days after the procedure. Risk factors which have been identified include myeloma, diabetes mellitus, hyperuricaemia, dehydration or fluid restriction before the urogram, large doses of contrast medium, repeated contrast examination over a short period, and elderly patients. Dawson (1985) in a review concluded that contrast medium nephrotoxicity was a real entity and stated that caution should be exercised in the high risk group. The radiologist who is concerned about the risks of intravenous contrast medium should always convince himself that the study is absolutely necessary before proceeding. There must also be adequate hydration before, during and after the procedure. There is a recommendation that the limited number of high dose urograms now being performed should be carried out with low osmolar contrast media (Grainger, 1984). Despite the cost, this is no doubt prudent because of the less significant haemodynamic effects of these agents and their lower toxicity. We have studied a group of 30 patients with uraemia who were randomly allocated to undergo high dose urography using ioxaglate or iohexol by carrying out pre-examination serum creatinine, urea, urinary N acetyl-B glucosaminidase and B 2 microglobulin estimations and repeating these
Read full abstract